Alemtuzumab Plus Oral Dexamethasone, Followed By Alemtuzumab Maintenance Or Allogeneic Transplantation In Ultra High-Risk Cll: Updated Results From A Phase Ii Study Of The Gcllsg And Fcgcll/MwStephan Stilgenbauer,Florence Cymbalista,Véronique Leblond,Alain Delmer,Silja Mack,Andreas Bühler,Dirk Winkler,Thorsten Zenz,Raymonde Busch,Stefan Ibach,Sylvain Choquet,Dartigeas Caroline,Bruno Cazin,Olivier Tournilhac,Till Seiler,Katja Zirlik,Jürgen Alt,Martin Sökler,Johannes Schetelig,Peter Dreger,Michael Hallek,Hartmut DöhnerBLOOD(2012)引用 10|浏览18暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要